Shree Ganesh Remedies has received approval from BSE for migrating the 10,006,446 Equity Shares of the Company from SME platform to Main Board platform of BSE with effective from November 25, 2020.
Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.